Articles related to ADVERSE EVENTS

CGRP inhibitors have shown promise in reducing migraine days and improving quality of life, but their wide-ranging effects throughout the body warrant careful consideration and long-term monitoring.

Semaglutide medications, while effective for weight loss, may carry unexpected mental health risks that require careful monitoring and consideration in clinical practice.

Semaglutide may alter taste perception gene expression in the tongue and modify brain reactions to sweet tastes, potentially enhancing weight loss effects beyond appetite suppression.

Collecting patient allergy information is futile if it’s not integrated into the prescribing process. This case demonstrates the legal and patient safety risks of inadequate medication safety systems.

In a randomized trial of 1,412 patients with acute ischemic stroke, reteplase was more likely to result in excellent functional outcomes at 90 days compared to alteplase.

A recent phase 3 trial demonstrates that a combination therapy of belantamab mafodotin, bortezomib, and dexamethasone leads to significantly longer progression-free survival in patients with relapsed or refractory multiple myeloma compared to a regimen including daratumumab.